Conflicts of Interest and Effective Oversight of Assisted Reproduction Using Donated Oocytes

Centers for Disease Control and Prevention, 2012 Assisted Reproductive Technology National Summary Report (2014), available at <http://nccd.cdc.gov/DRH_ART/Apps/NationalSummaryReport.aspx> (last visited May 1, 2015).

Kalfoglou A. L. Geller G. , “Navigating Conflict of Interest in Oocyte Donation: An Analysis of Donors' Experiences,” Women's Health Issues 10, no. 5 (2000): 226–239.

Kawwass J. F. Monsour M. Crawford S. Kissin D. M. Session D. R. Kulkarni A. D. Jamieson D. J. , “Trends and Outcomes for Donor Oocyte Cycles in the United States, 2000–2010,” JAMA 310, no. 22 (2013): 2426–2434.

National Research Council, “Two Principles for Identifying and Assessing Conflicts of Interest,” in Conflict of Interest in Medical Research, Education, and Practice (Washington, D.C.: The National Academies Press, 2009).

Dickens B. M. Cook R. J. , “Conflict of Interest: Legal and Ethical Aspects,” International Journal of Gynecology & Obstetrics 92, no. 2 (2006): 192–197.

See National Research Council, supra note 4.

Berg J. W. , “Risky Business: Evaluating Oocyte Donation,” American Journal of Bioethics 1, no. 4 (2001): 18–19.

See Kalfoglou Geller , supra note 2.

Dickenson D. , Property in the Body: Feminist Perspectives (Cambridge and New York: Cambridge University Press, 2007); Waldby C. , “Oocyte Markets: Women's Reproductive Work in Embryonic Stem Cell Research,” New Genetics and Society 27, no. 1 (2008): 19–31.

See Kalfoglou Geller , supra note 2.

Fertility Clinic Success Rate and Certification Act, 42 U.S.C. § 263a(1)-a(7).

137 Cong. Rec. E4145–02 (1991) (statement of Rep. Wyden).

Klein J. U. Sauer M. V. , “Ethics in Egg Donation: Past, Present, and Future,” Seminars in Reproductive Medicine 28, no. 4 (2010): 322–328; Daniels C. R. Heidt-Forsythe E. , “Gendered Eugenics and the Problematic of Free Market Reproductive Technologies: Sperm and Egg Donation in the United States,” Signs 37, no. 3 (2012): 719–747.

Robertson J. A. , “The Presumptive Primacy of Procreative Liberty,” in Children of Choice: Freedom and the New Reproductive Technologies (Princeton, NJ: Princeton University Press, 1994): At 22–42.

Roe v. Wade, 410 U.S. 113 (1973); Griswold v. Conn., 381 U.S. 479 (1965); Eisenstadt v. Baird, 405 U.S. 438 (1972); Lawrence v. Texas, 539 U.S. 558 (2003).

See Robertson , supra note 16.

Rao R. , “Equal Liberty: Assisted Reproductive Technology and Reproductive Equality,” George Washington Law Review 76, no. 6 (2008): 1457–1489.

National Conference of State Legislatures, “State Laws Related to Insurance Coverage for Infertility Treatment” (updated June 2014), available at <http://www.ncsl.org/research/health/insurance-coverage-for-infertility-laws.aspx> (last visited May 1, 2015); Asch A. Marmor R. , “Assisted Reproduction,” in Crowley M. , ed., From Birth to Death and Bench to Clinic: The Hastings Center Bioethics Briefing Book for Journalists, Policymakers, and Campaigns (Garrison, NY: The Hastings Center, 2008): 5–10.

La. Rev. Stat § 9:122 (2011).

Ind.Code § 35-46-5-3 (2014).

Ariz. Rev. Stat. Ann. § 36–1702 (2011).

Cal. Health & Safety Code § 125325.15 (2009).

See Kalfoglou Geller , supra note 2.

American Society for Reproductive Medicine, “2006 Guidelines for Gamete and Embryo Donation,” Fertility and Sterility 86, no. 5 (2006): S38–S50.

Ethics Committee of the American Society for Reproductive Medicine, “Financial Compensation of Oocyte Donors,” Fertility and Sterility 88, no. 2 (2007): 305–309 [hereinafter Financial Compensation].

Practice Committee of American Society for Reproductive Medicine, “Repetitive Oocyte Donation,” Fertility and Sterility 90, no. 5, Supp. (2008): S194–S195 [hereinafter Repetitive Donation].

Ethics Committee of the American Society for Reproductive Medicine, “Using Family Members as Gamete Donors or Surrogates,” Fertility and Sterility 98 no. 4 (2012): 797–803 [hereinafter Family Members].

Ethics Committee of the American Society for Reproductive Medicine, “Donating Spare Embryos for Stem Cell Research,” Fertility and Sterility 91, no. 3 (2009): 667–670 [hereinafter Spare Embryos].

Ethics Committee of the American Society for Reproductive Medicine, “Interests, Obligations and Rights of the Donor in Gamete Donation,” Fertility and Sterility 102, no. 3 (2012): 675–681 [hereinafter Rights of the Donor].

See Financial Compensation, supra note 28.

Levine A. D. , “Self-Regulation, Compensation, and the Ethical Recruitment of Oocyte Donors,” Hastings Center Report 40, no. 2 (2010): 25–36.

Alberta H. B. Berry R. M. Levine A. D. , “Compliance with Donor Age Recommendations in Oocyte Donor Recruitment Advertisements in the USA,” Reproductive Biomedicine Online 26, no. 4 (2013): 400–405 [hereinafter Donor Age Recommendations].

Alberta H. B. Berry R. M. Levine A. D. , “Risk Disclosure and the Recruitment of Oocyte Donors: Are Advertisers Telling the Full Story?” Journal of Law, Medicine & Ethics 42, no. 2 (2014): 232–243 [hereinafter Risk Disclosure and Recruitment].

Keehn J. Holwell E. Abdul-Karim R. Chin L. J. Leu C. Sauer M. V. Klitzman R. , “Recruiting Egg Donors Online: An Analysis of in Vitro Fertilization Clinic and Agency Websites' Adherence to American Society for Reproductive Medicine Guidelines,” Fertility and Sterility 98, no. 4 (2012): 995–1000.

Luk J. Petrozza J. C. , “Evaluation of Compliance and Range of Fees among American Society for Reproductive Medicine-Listed Egg Donor and Surrogacy Agencies,” Journal of Reproductive Medicine 53, no. 11 (2008): 847–852.

Kamakahi v. Am. Soc'y Reprod. Med., No. C 11–01781, 2013 WL 1768706 (U.S. Dist. N. Cal 2013).

Krawiec K. D. , “Egg-Donor Price Fixing and Kamakahi v. American Society for Reproductive Medicine,” The Virtual Mentor: VM 16, no. 1 (2014): 57–62.

Kenney N. J. McGowan M. L. , “Looking Back: Egg Donors' Retrospective Evaluations of Their Motivations, Expectations and Experiences During Their First Donation Cycle,” Fertility and Sterility 93, no. 2 (2010): 455–466.

Lindheim S. R. Frumovitz M. Sauer M. V. , “Recruitment and Screening Policies and Procedures Used to Establish a Paid Donor Oocyte Registry,” Human Reproduction 13, no. 7 (1998): 2020–2024.

See Kalfoglou Geller , supra note 2.

See Financial Compensation, supra note 28.

See Disclosure Risk Recruitment , supra note 36.

See Levine , supra note 34.

See Keehn , supra note 37.

Gurmankin A. D. , “Risk Information Provided to Prospective Oocyte Donors in a Preliminary Phone Call,” American Journal of Bioethics 1, no. 4 (2001): 3–13.

Id; Cialdini R. B. Cacioppo J. T. Bassett R. Miller J. A. , “Low-Ball Procedure for Producing Compliance: Commitment Then Cost,” Journal of Personality and Social Psychology 36, no. 5 (1978): 463–476.

Tversky A. Kahneman D. , “Judgment under Uncertainty: Heuristics and Biases,” Science 185, no. 4157 (1974): 1124–1131; Brewer N. T. Chapman G. B. Schwartz J. A. Bergus G. R. , “The Influence of Irrelevant Anchors on the Judgments and Choices of Doctors and Patients,” Medical Decision Making 27, no. 2 (2007): 203–211.

See Gurmankin , supra note 49.

Practice Committee of American Society for Reproductive Medicine, and Practice Committee of Society for Assisted Reproductive Technology, “Recommendations for Gamete and Embryo Donation: A Committee Opinion,” Fertility and sterility 99, no. 1 (2013): 47–62.

See Donor Age Recommendations, supra note 35.

Almeling R. , “Selling Genes, Selling Gender: Egg Agencies, Sperm Banks, and the Medical Market in Genetic Material,” American Sociological Review 72, no. 3 (June 2007): 319–340.

Id.; see Lindheim Frumovitz Sauer , supra note 42.

See Lindheim Frumovitz Sauer , supra note 42.

The New York State Task Force on Life and the Law, Assisted Reproductive Technologies: Analysis and Recommendations for Public Policy (New York: The New York State Task Force on Life and the Law, 1998); Robertson J. A. , “Is There an Ethical Problem Here?” Hastings Center Report 40, no. 2 (2010): 3; see Rights of the Donor, supra note 32.

See Almeling , supra note 56.

See Kenney McGowan , supra note 41.

Skillern A. A. Cedars M. I. Huddleston H. G. , “Oocyte Donors' Comprehension as Assessed by the EDICT (Egg Donor Informed Consent Tool),” Fertility and Sterility 101, no. 1 (2014): 248–251.

Crockin S. L. Daar J. , “American Society for Reproductive Medicine Updated Consent Forms,” Virtual Mentor 16, no. 4 (April 2014): 302–303.

See Kalfoglou Geller , supra note 2.

See Rights of the Donor, supra note 32.

Schaefer G. O. Sinaii N. Grady C. , “Informing Egg Donors of the Potential for Embryonic Research: A Survey of Consent Forms from US in Vitro Fertilization Clinics,” Fertility and Sterility 97, no. 2 (2012): 427–433.

Bodri D. Guillén J. J. Polo A. Trullenque M. Esteve C. Coll O. , “Complications Related to Ovarian Stimulation and Oocyte Retrieval in 4052 Oocyte Donor Cycles,” Reproductive Biomedicine Online 17, no. 2 (2008): 237–243; Maxwell K. N. Cholst I. N. Rosenwaks Z. , “The Incidence of Both Serious and Minor Complications in Young Women Undergoing Oocyte Donation,” Fertility and Sterility 90, no. 6 (2008): 2165–2171.

Mayo Clinic Staff, “Ovarian Hyperstimulation Syndrome,” 2014, available at <http://www.mayoclinic.org/diseases-conditions/ovarian-hyperstimulation-syndrome-ohss/basics/definition/con-20033777> (last visited May 1, 2015).

See Kalfoglou Geller , supra note 2.

Kushnir V. A. Khanna P. Barad D. A. Gleicher N. , “Establishment of Comparative Performance Criteria for IVF Centers: Correlation of Live Birth Rates in Autologous and Donor Oocyte IVF Cycles,” Reproductive Biology and Endocrinology 12, no. 1 (2014): 122.

See Financial Compensation, supra note 28.

See Kawwass , supra note 3.

Sunkara S. K. Rittenberg V. Raine-Fenning N. Bhattacharya S. Zamora J. Coomarasamy A. , “Association between the Number of Eggs and Live Birth in IVF Treatment: An Analysis of 400 135 Treatment Cycles,” Human Reproduction 26, no. 7 (2011): 1768–1774.

Bodri D. , “Risk and Complications Associated with Egg Donation,” in Sauer M. V. , ed., Principles of Oocyte and Embryo Donation (Springer: London, 2013): At 205–219.

See Kawwass , supra note 3.

See Kalfoglou Geller , supra note 2.

See Almeling , supra note 56.

See Financial Compensation, supra note 28.

See Keehn , supra note 37.

See Repetitive Donation, supra note 29.

See Kenney McGowan , supra note 41.

Almeling R. , Sex Cells: The Medical Market for Eggs and Sperm (University of California Press, 2011): At 119.

42 U.S.C. § 1395nn (1995).

Hudson N. Culley L. , “Assisted Reproductive Travel: UK Patient Trajectories,” Reproductive Biomedicine Online 23, no. 5 (2011): 573–581.

42 CFR § 121 (2007).

Truog R. D. , “The Ethics of Organ Donation by Living Donors,” New England Journal of Medicine 353, no. 5 (2005): 444–446.

See Family Members, supra note 30.

McKneally M. F. , “Beyond Disclosure: Managing Conflicts of Interest to Strengthen Trust in Our Profession,” Journal of Thoracic and Cardiovascular Surgery 133, no. 2 (2007): 300–302.

See Financial Compensation, supra note 28.

Stiver v. Parker, 975 F.2d 261 (6th Cir. 1992).

See Kalfoglou Geller , supra note 2.

See Family Members, supra note 30; Financial Compensation, supra note 28; Embryos Spare , supra note 31.

See Rules 1.7–1.12, ABA Model Rules of Professional Conduct, available at <http://www.americanbar.org/groups/professional_responsibility/publications/model_rules_of_professional_conduct/model_rules_of_professional_conduct_table_of_contents.html> (last visited May 1, 2015).

See McKneally , supra note 97.

Moore v. Regents of the University of California, 793 P2d 479 (S. Ct. Cal. 1990); Murthy v. Abbott Labs., 847 F. Supp. 2d 958, 972 n.5 (S.D. Tex. 2012).

See Kalfoglou Geller , supra note 2.

See Dickenson , supra note 10; Daniels Heidt-Forsythe , supra note 15; Kenney McGowan , supra note 40.

See McKneally , supra note 97.

Cain D. M. Loewenstein G. Moore D. A. , “The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest,” Journal of Legal Studies 34, no. 1 (2005): 1–25.

See Kalfoglou Geller , supra note 2.

See Fertility Clinic Success Rate and Certification Act, supra note 12.

See Financial Compensation, supra note 28.